5 Best Low Risk High Growth Stocks to Buy Right Now

2. Eli Lilly and Company (NYSE:LLY)

Eli Lilly and Company (NYSE:LLY) is often referred to as the leading contender to become the first trillion-dollar pharmaceutical company. Following its massive transformation into a cardiometabolic leader, Lilly is seen as a growth stock in a value sector. This growth is currently being powered by a historic duopoly in the obesity and diabetes markets. In February, Lilly issued 2026 revenue guidance of $80–$83 billion, nearly 4% above consensus. This is driven by the unprecedented demand for Mounjaro and Zepbound. In March, Lilly released Phase 3 data for Foundayo, its once-daily obesity pill. Analysts view this as a massive growth kicker, as it broadens the market to patients who prefer a pill over an injection, significantly increasing the total addressable market. Recent Phase 3 results for retatrutide showed weight loss of up to 16.8%, reinforcing Lilly’s pipeline dominance through the end of the decade.

READ MORE: 15 Best Stocks to Buy According to Billionaire Ray Dalio.

For risk-averse investors, the balance sheet and margins of Eli Lilly and Company (NYSE:LLY) provide a tech-like safety net. The firm maintains an elite 83% gross profit margin and a 97% return on equity. This level of profitability allows it to absorb pricing pressures and self-fund its $7 billion+ annual capital expenditures. With a Beta of 0.50, the company is roughly half as volatile as the broader S&P 500. It acts as a defensive safe-haven during market downturns while still offering growth-stock returns. In early 2026, Lilly announced a $3.5 billion investment in a new Lehigh Valley facility. By owning its supply chain, Lilly de-risks itself against the shortages that have plagued competitors like Novo Nordisk.